Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To define the pharmacokinetic characteristics of Nystatin LF IV (intravenous) in human
subjects with AIDS-related complex (ARC) after administration of a single IV dose at each of
4 dose levels.